Copy Link Print Information

Emfizatamab

(Synonyms: GNC-038)
Revisión del cliente

Based on 1 Customer Validation

Emfizatamab (GNC-038) is a monoclonal antibody against CD19/CD3E/TNFRSF9/PD-L1. Emfizatamab exhibits antitumor activity, being capable of activating CD3 and 4-1BB signals on T cells, as well as targeting the high expression of CD19 or PD-L1 on tumor cells. Emfizatamab functions as a CD19-specific T cell engager by mediating direct antitumor activity. Emfizatamab can also overcome the inhibition of T cells by PD-L1. Emfizatamab can be used in the research of tumors such as R/R non-Hodgkin lymphoma or acute lymphoblastic leukemia.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 95.495%
  • No. CAS: 2559704-23-1
  • Peso molecular:303.229 kDa
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Emfizatamab
  • Experimental Validation Results for Emfizatamab
  • Experimental Validation Results for Emfizatamab
  • Experimental Validation Results for Emfizatamab
  • Experimental Validation Results for Emfizatamab
  • Emfizatamab Chemical Structure
    Emfizatamab Chemical Structure
No. CAS: 2559704-23-1
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Emfizatamab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Ver todos los productos específicos de isoformas TNF Receptor

More

Ver todos los productos específicos de isoformas Interleukin Related

More
Keywords
100 mg

Obtener un presupuesto En stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    (scFv-kappa-heavy)-G1_L-kappa-(scFv-heavy-kappa)-(scFv-heavy-kappa)

  • 1/16

    Immobilized CD3 epsilon Protein, Human (HEK293, His, HY-P70506) can bind Emfizatamab. The EC50 for this effect is 27.4 ng/mL.

  • 1/16

    Immobilized CD19 Protein, Human (HEK293, His, HY-P74330) can bind Emfizatamab. The EC50 for this effect is 57.29 ng/mL.

  • 1/16

    Immobilized 4-1BB/TNFRSF9 Protein, Human, HY-P7125) can bind Emfizatamab. The EC50 for this effect is 1.358 ng/mL.

  • 1/16

    Immobilized PD-L1 Protein, Human (HEK293, HY-P73361) can bind Emfizatamab. The EC50 for this effect is 64.84 ng/mL.

  • Emfizatamab Chemical Structure
    1/16
  • Emfizatamab
  • Immobilized CD3 epsilon Protein, Human (HEK293, His, HY-P70506) can bind Emfizatamab. The EC50 for this effect is 27.4 ng/mL.
  • Immobilized CD19 Protein, Human (HEK293, His, HY-P74330) can bind Emfizatamab. The EC50 for this effect is 57.29 ng/mL.
  • Immobilized 4-1BB/TNFRSF9 Protein, Human, HY-P7125) can bind Emfizatamab. The EC50 for this effect is 1.358 ng/mL.
  • Immobilized PD-L1 Protein, Human (HEK293, HY-P73361) can bind Emfizatamab. The EC50 for this effect is 64.84 ng/mL.
  • (scFv-kappa-heavy)-G1_L-kappa-(scFv-heavy-kappa)-(scFv-heavy-kappa)